Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Allan-Herndon-Dudley Syndrome in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
People's Primary Healthcare Initiative (PPHI), Sindh
University of Stellenbosch
Kwong Wah Hospital
Kiplin
PPI Healthcare Consulting Ltd
Exonhit
World Heart Federation
Novadaq Technologies ULC, now a part of Stryker
Nina Rica Wium Geiker
XEOS Medical
Hospital Dos de Maig
American Brain Foundation
Lyman Medical Research Foundation, Inc.
Landspitali University Hospital
Orthopaedic & Neurosurgery Specialists
Biohm Health, LLC
Eliem Therapeutics (UK) Ltd.
Theusinger Oliver M.
Celgene
Bledina
View Full List
Medical Conditions
Abdominal Compartment Syndrome
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
Neutrophilia Acute
HIV Pre-exposure Prophylaxis Use
Venous Puncture
Acute Endophthalmitis Post-operative
Hemopathies
Skeletal Muscle Energy Metabolism
Mineralocorticoid Excess
Pelvic and Groin Areas Biopsy
Hypogonadism, Hypogonadotropic
Ferritin Threshold
Bioequivalence, AUC, Cmax, Pharmacokinetics
Modality of Discharge Instructions
Osteopathic Manipulative Treatment
Human Risk Factors
Major Depressive Disorder, Recurrent Episode, Severe
Central Motor Disorders
Reading Disability
Chondrosis
View Full List
Drug Interventions
Risperidone
Apatinib
Niraparib
Anti-PD1 antibody, nimotuzumab and capecitabine
Test varnish
Pregabalin
Lenalidomide
Amantadine Sulfate
Systemic intravenous lidocaine infusion
Leuprolide acetate 11.25 mg
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
LY2216684
MYL-1501D product using manufacture process VI
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Ranitidine
Pacritinib
Carbetocin
Neridronate
Enteral oxygen therapy
Betamethasone
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Belgium
Contract Research Organizations in Congo
Contract Research Organizations in Ecuador
Contract Research Organizations in Germany
Contract Research Organizations in Latvia
Contract Research Organizations in Madagascar
Contract Research Organizations in Malawi
Contract Research Organizations in Qatar
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uzbekistan
Contract Research Organizations in Venezuela
Contract Research Organizations in Vietnam
CRO list by country
CROs in Iran
Farzan Clinical Research
SGS
All CROs in Iran
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe